COMMUNIQUÉS West-GlobeNewswire

ARCPOINT ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT AND WARRANT AMENDMENTS

31/07/2024 - 20:48

Not for Dissemination in the United States or through U.S. Newswire Services Greenville, South Carolina, July 31, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to [...]

NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call

31/07/2024 - 20:03

WOBURN, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2024 second quarter business and financial highlights before the opening of the market on [...]

AMN Healthcare Launches Executive Advisory Board

31/07/2024 - 19:00

Move brings experienced, accomplished health leader to help AMN address healthcare industry’s workforce challenges DALLAS, July 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN) is taking steps to further [...]

Betterguards Unveils New Sports Tech, The BetterGuard 2.0

31/07/2024 - 17:26

Intelligent ankle brace technology offers preventative support against common ankle injuries NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- Betterguards , a next-generation sports technology innovator, announces the launch [...]

20 Facilities Ranked as the 2024 Most Beautiful Hospitals in the U.S.

31/07/2024 - 16:00

Hospitals chosen for their exceptional facilities, staff and patient experience in contest hosted by national staffing firm Soliant ATLANTA, July 31, 2024 (GLOBE NEWSWIRE) -- National staffing firm Soliant today named [...]

BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

31/07/2024 - 15:45

Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or “Company”), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal [...]

Natural Harmony Foods Inc. Completes Financial Audits for 2022 & 2023

31/07/2024 - 15:30

Unlocking Funds to Accelerate Operations NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- Publicly-held Natural Harmony Foods Inc. (OTC: NHYF) is delighted to report the completion of its financial statement audits for the [...]

Palisade Bio Participates in Virtual Investor “What this Means” Segment

31/07/2024 - 15:15

Mitch Jones, MD, PhD, CMO of Palisade Bio highlights recent findings from a microbiome study confirming local bioactivation of lead product candidate, PALI-2108 Carlsbad, CA, July 31, 2024 (GLOBE NEWSWIRE) -- Palisade [...]

Rhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old

31/07/2024 - 15:10

IMCIVREE now authorized as treatment of obesity and control of hunger in adult patients and pediatric patients 2 years old or older with Bardet Biedl syndrome or POMC, PCSK1, or LEPR deficiency BOSTON, July 31, 2024 ( [...]

Arch Biopartners Closes Non-Brokered Private Placement

30/07/2024 - 22:47

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed the non-brokered private placement disclosed in a press [...]

TRACON Pharmaceuticals Announces it Will Wind Down Operations

30/07/2024 - 22:44

SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision was made at a special [...]

DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results

30/07/2024 - 22:30

Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut [...]

DBV Technologies présente les dernières avancées du programme Viaskin Peanut chez les enfants de 4 à 7 ans et les tout-petits de 1 à 3 ans et publie ses résultats financiers du deuxième trimestre et premier semestre 2024.

30/07/2024 - 22:30

DBV Technologies présente les dernières avancées du programme Viaskin Peanut chez les enfants de 4 à 7 ans et les tout-petits de 1 à 3 ans et publie ses résultats financiers du deuxième trimestre et premier semestre [...]

MannKind Corporation to Hold 2024 Second Quarter Financial Results Conference Call on August 7, 2024

30/07/2024 - 22:30

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , announced today that it will report its second quarter 2024 financial results before the market opens [...]

Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024

30/07/2024 - 22:15

MINNEAPOLIS, July 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical [...]

MacroGenics Provides Vobramitamab Duocarmazine Update

30/07/2024 - 22:10

Abstract of clinical data accepted for poster presentation at ESMO Congress 2024 in September ESMO poster to include protocol-defined TAMARACK Phase 2 mCRPC study data, including pre-defined landmark primary endpoint of [...]

Inari Medical Announces Chief Financial Officer Retirement and Succession Plan

30/07/2024 - 22:10

Mitch Hill to retire as Chief Financial Officer, to be succeeded by Kevin Strange in October 2024 IRVINE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company [...]

Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

30/07/2024 - 22:10

ZUG, Switzerland, July 30, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ [...]

FibroGen to Report Second Quarter 2024 Financial Results

30/07/2024 - 22:07

SAN FRANCISCO, July 30, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce second quarter 2024 financial results on Tuesday, August 6 after the market close. FibroGen will also conduct a conference [...]